Navigation Links
Alacrita Asks "Are We All Biotech Now?"
Date:6/23/2011

LONDON, June 23, 2011 /PRNewswire/ --


 

Alacrita, which is changing the face of life science consulting, has published an insight into the future development of the global pharmaceutical industry. In the whitepaper, Alacrita sets out a vision of how the industry may look as it evolves in response to the challenges it faces and reflects on the decisions it has made. In particular, Alacrita considers whether the industry will reverse the unparalleled consolidation seen in the past 25 years to produce a diversity of strategically independent participants that operate along an extended pharma value chain. Such a split into distinct innovators, service providers and marketers would represent a wholesale adoption of the biotech model.

The article, written by Alacrita partners Anthony Walker and Rob Johnson, was published in the June issue of Business Development and Licensing Journal (Ref. 1) and is available at http://www.alacritaconsulting.com.

"The pharma industry has undergone significant change over the last decade as it has tried to maintain double digit growth and profitability in the face of decreasing R&D productivity, looming patent cliffs and increased focus on containing healthcare costs," said Dr Walker. "Aggressive M&A strategies haven't solved the problem, and we are seeing heightened activity in franchise management where portfolios are being vigorously reshaped through a combination of acquisition, licensing and partnering on the one hand, and project terminations and divestments on the other."  

"Pharma companies are increasingly becoming more focused and streamlined, with a greater emphasis on building core strengths and shedding non-core assets. Funds are being shifted to activities or functions that add the greatest value and if 'greatest value' requires a function to be carried out by an external party,
'/>"/>

SOURCE Alacrita
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
2. Yongye Biotechnology International Retains CCG Investor Relations
3. ThirdBiotech Announces Kemeta as Newest Sponsor
4. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
5. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
6. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
7. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
8. China Kangtai Cactus Biotech Announces Record Second Quarter Results
9. Yongye Biotechnology International Announces Second Quarter Results
10. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... TeselaGen Biotechnology has received a ... their bioCAD/CAM software suite, which uses synthetic biology ... Business Innovation Research Phase II grant will be used ... from the Lawrence Berkeley National Laboratory. j5 was developed ... laboratory that develops alternative fuel technologies for the Department ...
(Date:10/1/2014)... 30, 2014 This report analyzes ... US$ Million by the following Product Segments: ... Specific end-use segments also analyzed are Pharmaceuticals ... The report provides separate comprehensive analytics for ... East, and Latin America. Annual estimates and ...
(Date:9/30/2014)... German . , The ... a semiconductor layer. Quantum dots are small structures that spontaneously ... short laser pulse is fired at the photonic crystal, its ... change in the electromagnetic field around it. This change can ... the dot. As soon as the refractive index recovers its ...
(Date:9/30/2014)... release is available in German . ... Technische Universitt Mnchen (TUM) have demonstrated a new kind ... show that future computer chips could be based on ... the main enabling technology of the semiconductor industry ... the TUM researchers and collaborators at the University of ...
Breaking Biology Technology:TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24Global Specialty Enzymes Industry 25Global Specialty Enzymes Industry 26Ultrafast remote switching of light emission 2A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3
... Metabolex, Inc., a,biopharmaceutical company focused on ... for the treatment of metabolic diseases,announced today ... company as chief,financial officer. Mr. Hill brings ... including expertise in business,development, treasury management and ...
... a ... ... TSX symbol: SBS, CALGARY, April 14 /PRNewswire-FirstCall/ - Botaneco, a wholly ... of oleosome technology in personal care,OTC and topical pharmaceutical markets, today announced ...
... April 11 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... company that identifies,develops and commercializes differentiated products for ... on two of its,anti-cancer drugs, nimotuzumab and tesmilifene, ... Research (AACR) Annual Meeting held from,April 12-16, 2008 ...
Cached Biology Technology:Metabolex Appoints Donald Hill as Chief Financial Officer 2Botaneco Announces Launch of Second Generation Oleosome Product 2Botaneco Announces Launch of Second Generation Oleosome Product 3YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING 3
(Date:9/30/2014)... This news release is available in German . ... caviar, are among the most expensive foods in the world. ... to find them. But the distinctive smell of truffles is ... and French scientists under the direction of the Goethe University ... largely produced by soil bacteria which are trapped inside truffle ...
(Date:9/30/2014)... some hope: A new research report published in October ... , explains how scientists developed a synthetic version of ... development in human and mouse eggs similar to the ... during fertilization. , "We believe that the results of ... understanding of human fertilization by providing a precise answer ...
(Date:9/30/2014)... KONG , Sept. 30, 2014 Winners of ... Economist Events, Innovation Summit scheduled to take place at the JW ... the summit, the award winners will share their experiences and the ... who have made a proven innovation over the past decade, will ... the night before the summit. It will be the first ...
Breaking Biology News(10 mins):On the trail of the truffle flavor 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... a groundbreaking new gene sequencing technology, researchers have demonstrated ... in Acute Myeloid Leukemia, AML, one of the most ... by Pacific Biosciences, allows for the rapid and comprehensive ... The findings, published online April 15 in Nature ...
... There are twice as many emperor penguins in ... study released today by an international team of researchers ... an entire species from space provides an important benchmark ... population of this iconic bird. Scientists from the ...
... What can surnames tell us about the culture, genetics and ... by Chinese researchers who have traced the evolution of surnames ... Physical Anthropology , reveals how surnames can act as a ... migrations and historical events which shaped modern China. ...
Cached Biology News:Scientists identify FLT3 gene as a valid therapeutic target in acute myeloid leukemia 2Scientists complete first-ever emperor penguin count from space 2What's in a surname? New study explores what the evolution of names reveals about China 2
Anti-TWIK-1 Immunogen: Purified peptide from amino acids 53-69 of human TWIK-1 (Accession number O00180)....
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
Biology Products: